NASDAQ:ENLV   Enlivex Therapeutics Ltd.
The drug Allocetra saves the lives of patients in a severe condition from the virus in Israel.
The end of the Phase 2 trial is about to be published soon.
preventing or treating complications associated with sepsis, COVID-19, bone-marrow transplants and solid tumors.
At the end of 2021, the drug report on patients will be published.
Last chance before takeoff.
Opinion only not a professional recommendation.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。